BioLineRx (BLRX) Other Non-Current Assets (2011 - 2019)
BioLineRx's Other Non-Current Assets came in at $59,000 for the quarter ended Sep 30, 2019, down 10.6% from $66,000 a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Other Non-Current Assets (2011 - 2019) Analysis & Trends
As of Dec 31, 2018, BioLineRx's Other Non-Current Assets was $56,000, down 8.2% from the prior year.
- Other Non-Current Assets carries a five-year compound annual growth rate of 2.7% (years ended Dec 2013 to Dec 2018).
- Going back by year, Other Non-Current Assets was $61,000 in the year ended Dec 31, 2017 (+17.3%), $52,000 in the year ended Dec 31, 2016 (-10.3%), $58,000 in the year ended Dec 31, 2015 (+18.4%) and $49,000 in the year ended Dec 31, 2014 (unchanged).
- The five-year range for quarterly Other Non-Current Assets is $49,000 (the quarter ended Dec 31, 2014) to $66,000 (the quarter ended Sep 30, 2018).
- Year-over-year, Other Non-Current Assets has declined for four consecutive quarters, with growth averaging 2.9% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Assets over five years came in the quarter ended Sep 30, 2015 (growth of 55.6%), and the weakest in the quarter ended Sep 30, 2019 (a decline of 10.6%).
- Business Quant data shows BLRX's Other Non-Current Assets at $60,000 (quarter ended Jun 30, 2019), $55,000 (quarter ended Mar 31, 2019) and $56,000 (quarter ended Dec 31, 2018) in the three quarters before the quarter ended Sep 30, 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | 60,000.00 |
| Mar 31, 2019 | 55,000.00 |
| Dec 31, 2018 | 56,000.00 |
| Sep 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 63,000.00 |
| Mar 31, 2018 | 60,000.00 |
| Dec 31, 2017 | 61,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 53,000.00 |
| Mar 31, 2017 | 55,000.00 |
| Dec 31, 2016 | 52,000.00 |
| Sep 30, 2016 | 54,000.00 |
| Jun 30, 2016 | 54,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Dec 31, 2015 | 58,000.00 |
| Sep 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 57,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Dec 31, 2014 | 49,000.00 |
API Access
BioLineRx Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();